BIOMARIN PHADRNBIOMARIN PHADRNBIOMARIN PHADRN

BIOMARIN PHADRN

No trades
See on Supercharts

Key stats

Market capitalization
‪89.29 B‬BRL
Dividend yield (indicated)
Price to earnings Ratio (TTM)
Basic EPS (TTM)
Net income
Revenue
Shares float
Beta (1Y)
0.34

About BIOMARIN PHADRN

CEO
Alexander Hardy
Headquarters
San Rafael
Founded
1997
ISIN
BRB1MRBDR001
FIGI
BBG00RD5Q2Y4
BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997, and is headquartered in San Rafael, CA.

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where B1MR34 is featured.